A total of 19 species
The widespread use of antibiotics in animal feed to reduce disease and improve animal performance, and thus profitability, has come under criticism for increasing the antibiotic resistance of many bacteria, including some pathogens. Organisms which cause respiratory and cutaneous infections (Streptococcus pneumoniae, Streptococcus pyogenes and staphylococci) as well as diarrhea, urinary infection and sepsis (Enterobacteriaceae, Pseudomonas families) are now resistant to many of the older antibiotics (13) . This concern, with antimicrobial agent becoming less effective, has prompted many investigations into mechanisms to replace antibiotics with probiotic agents in animal feed rations (7) .
The administration of probiotic agents in animal feeds has met with limited success and produced highly variable results (16) . Most of the preparations contain lactobacillus preparations, and more recently bifidobacteria species have been added to many of the probiotic preparations.
Lactobacilli tend to occupy the more proximal area of the gastrointestinal tract (GI) (16, 18) , while bifidobacteria inhabit principally the large intestine or cecal areas (11) .
Bifidobacteria inhibit the growth of many undesirable organisms in the lower GI (5) through the production of lactic and acetic acid (15) . By controlling intes-tinal pH it is possible to restrict the growth of pathogens and putrefactive bacteria and in turn reduce the production of phenols, ammonia, steroid metabolites , bacterial toxins as well as vasoconstricting amines (5) . To be of benefit to the host, bifidobacteria must receive sources of carbohydrate, termed bifidogenic factors (10) , for metabolism in the lower bowel/ceca area. Ideally such compounds should be not be metabolized by the host and arrive intact at the distal end of the small intestine and colon/cecal areas of the GI tract (9) . 
Some intestinal pathogens can metabolize short-chain ).OS; thus in order to maximize the e).).icient use o). ).OS, it is necessary to determine which Bi).idobacterium spp. metabolize ).OS, and what is the most e).
).icient chain length and source o). this polysaccharide. The purpose o). the present study is to (1) select strains o). bi).idobacteria which can metabolize long-chain ).OS such as inulin and (2) Table  2 ).or composition) Table 1 . Bifidobacterium spp. used in the present study and Lomb, Rochester, NY) . When the influence of pH, temperature and atmosphere were being determined, the carbohydrate was 0.5% (w/v) inulin from dahlia tubers. When the effect of pH was being determined, pH of TPY was adjusted to 6.0-9.0 using HC1 prior to sterilization. When the effect of atmosphere was being considered, cultures were incubated in the presence and absence of cysteine hydrochloride (0.05% w/v) , either aerobically, anaerobically, or in a CO2 chamber (Napco Model 6200, Napco Levan was not a good substrate for growth of animal strains of bifidobacteria. Muramatsu et al. (12) also showed that bifidobacteria from human origin failed to utilize levan. Fibruline, consisting of a large proportion of short-chain FOS, was the best inulin preparation, confirming previous observations that bifidobacteria preferred short-chain FOS to inulin (8, 12) .
The ability of raffinose and inulin to induce inulinase production is shown in Fig. 3 . Significant inulinase was only produced with inulin as carbohydrate source. When inulinase production by individual strains was compared, B. cuniculi gave higher activity than CFAR 323, CFAR 348 and B. minimum (Table 6 ). CFAR 70 gave greater activities than CFAR 323, and also produced higher levels of inulinase on raffinose and in the absence of carbohydrate (Table 6 ). (p•…0.05) less growth was also found at 6.5 compared to 6.0, 7.5, and 8.0 (Fig.  4) . 
